Core-shell designed scaffolds of alginate/alpha-tricalcium phosphate for the loading and delivery of biological proteins

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 4, 2013, Pages 1103-1112

  Perez, Roman A ^a   Kim, Hae Won ^a,b,c  

^a BK21 Plus NBM Global Research Center for Regenerative Medicine   (South Korea)

^b Dankook University   (South Korea)

^c Dankook University   (South Korea)

Author keywords

tricalcium phosphate; Alginate hardening; Bone regeneration; Bone scaffolds; Protein delivery

Indexed keywords

BONE REGENERATION; BONE SCAFFOLDS; GROWTH FACTOR DELIVERY; MECHANICAL STIFFNESS; PROTEIN DELIVERY; REGENERATIVE CAPACITY; THERAPEUTIC MOLECULES; TRI-CALCIUM PHOSPHATES;

HARDENING; PROTEINS; SCAFFOLDS (BIOLOGY); SHELLS (STRUCTURES); TISSUE;

LOADING;

ALGINIC ACID; CALCIUM CHLORIDE; CALCIUM PHOSPHATE; CYTOCHROME C; MOLECULAR SCAFFOLD;

ARTICLE; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CROSS LINKING; PROTEIN DEPLETION; TIME;

ALGINATES; ANIMALS; CALCIUM PHOSPHATES; CYTOCHROMES C; DRUG DELIVERY SYSTEMS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS;

EID: 84876179736     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34406     Document Type: Article

References (22)

1. Ziegler J, Mayr-Wohlfart U, Kessler S, Breitig D, Gunther KP. Adsorption and release properties of growth factors from biodegradable implants. J Biomed Mater Res 2002;59:422-428.
2. King WJ, Krebsbach PH. Growth factor delivery: How surface interactions modulate release in vitro and in vivo. Adv Drug Deliv Rev 2012;64:1239-1256.
3. Yun YR, Won JE, Jeon E, Lee S, Kang W, Jo H, Jang JH, Shin US, Kim HW. Fibroblast growth factors: Biology, function, and application for tissue regeneration. J Tissue Eng 2010;1:218142 (doi:10.4061/2010/218142).
4. Wenk E, Meinel AJ, Wildy S, Merkle HP, Meinel L. Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering. Biomaterials 2009;30:2571-2581.
5. Fransson J, Hallon D, Florin-Robertsson E. Solvent effects on the solubility and physical stability of human insulin-like growth factor I. Pharm Res 1997;14:606-612.
6. van de Weert M, Hennink WE, Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res 2000;17: 1159-1167.
7. Whitaker MJ, Quirk RA, Howdle SM, Shakesheff KM. Growth factor release from tissue engineering scaffolds. J Pharm Pharmacol 2001;53:1427-1437.
8. Perez RA, Won JE, Knowles JC, Kim HW. Naturally and synthetic smart composite biomaterials for tissue regeneration. Adv Drug Deliv Rev.2012, doi:10.1016/j.addr.2012.03.009.
9. Mourino V, Boccaccini AR. Bone tissue engineering therapeutics: Controlled drug delivery in three-dimensional scaffolds. J R Soc Interface 2010;7:209-227.
10. Sokolsky-Papkov M, Agashi K, Olaye A, Shakesheff K, Domb AJ. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59:187-206.
11. Kempen DHR, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WJ. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 2009;30:2816-2825.
12. Patel ZS, Young S, Tabata Y, Jansen JA, Wong MEK, Mikos AG. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008; 43:931-940.
13. Shah NJ, Macdonald ML, Beben YM, Padera RF, Samuel RE, Hammond PT. Tunable dual growth factor delivery from polyelectrolyte multilayer films. Biomaterials 2011;32:6183-6193.
14. Young S, Patel ZS, Kretlow JD, Murphy MB, Mountziaris PM, Baggett LS, Ueda H, Tabata Y, Jansen JA, Wong M, Mikos AG. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng A 2009;15:2347-2362.
15. Oddo L, Masci G, Di Meo C, Capitani D, Mannina L, Lamanna R, De Santis S, Alhaique F, Coviello T, Matricardi P. Novel thermosensitive calcium alginate microspheres: Physic-chemical characterization and delivery properties. Acta Biomater 2010;6: 3657-3664.
16. Tan R, She Z, Wang M, Fang Z, Liu Y, Feng Q. Thermo-sensitive alginate-based injectable hydrogel for tissue engineering. Carbohydr Polym 2012;87:1515-1521.
17. Perez RA, Del Valle S, Altankov G, Ginebra MP. Porous hydroxyapatite and gelatin/hydroxyapatite microspheres obtained by calcium phosphate cement emulsion. J Biomed Mater Res B 2011; 97B:156-166.
18. Perez RA, Altankov G, Jorge-Herrero E, Ginebra MP. Micro- and nanostructured hydroxyapatite-collagen microcarriers for bone tissue-engineering applications. J Tissue Eng Regen Med 2012, doi: 10.1002/term.530.
19. Perez RA, Kim HW, Ginebra MP. Polymeric additives to enhance the functional properties of calcium phosphate cements. J Tissue Eng 2012, doi: 10.1177/2041731412439555.
20. Lee GS, Park JH, Shin US, Kim HW. Direct deposited porous scaffolds of calcium phosphate cement with alginate for drug delivery and bone tissue engineering. Acta Biomater 2011;7: 3178-3186.
21. Perez R, Ginebra M, Spector M. Cell response to collagen-calcium phosphate cement scaffolds investigated for nonviral gene delivery. J Mater Sci Mater Med 2011;22:887-897.
22. Acarturk ST. Calcium alginate microparticles for oral administration: I: Effect of sodium alginate type on drug release and drug entrapment efficiency. J Microencapsul 1999;16:275-290.